AstraZeneca PLC Ordinary Shares (AZN)
Deferred Revenue
$0.00
Quarterly · Period ending: · USD
AZN Deferred Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
AZN Quarterly Deferred Revenue (-$813.56M → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
AZN deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 1,234,000,000 | |
| 1,141,000,000 | |
| 1,010,000,000 | |
| -9,753,000,000 | |
| 1,224,000,000 | |
| 1,273,000,000 | |
| 1,462,000,000 | |
| -6,437,000,000 | |
| 1,513,000,000 | |
| 1,576,000,000 | |
| 1,646,000,000 | |
| -5,876,000,000 | |
| 1,534,000,000 | |
| 1,960,000,000 | |
| 1,796,000,000 | |
| -6,504,000,000 | |
| 2,065,000,000 | |
| 2,049,000,000 | |
| 2,330,000,000 | |
| -5,839,000,000 | |
| 2,695,000,000 | |
| 2,827,000,000 | |
| 3,316,000,000 | |
| -4,580,000,000 | |
| 3,144,000,000 | |
| 2,991,000,000 | |
| 2,818,000,000 | |
| -3,679,000,000 | |
| 2,927,000,000 | |
| 2,738,000,000 | |
| 3,166,000,000 | |
| -3,430,000,000 | |
| 3,491,000,000 | |
| 4,757,000,000 | |
| 5,758,000,000 | |
| 6,898,000,000 | |
| 7,598,000,000 | |
| 7,466,000,000 | |
| 7,100,000,000 | |
| 6,937,000,000 | |
| 6,643,000,000 | |
| 6,214,000,000 | |
| 5,146,000,000 | |
| 1,878,000,000 | |
| 4,536,000,000 | |
| 4,257,000,000 | |
| 4,071,000,000 | |
| 2,172,000,000 | |
| 3,393,000,000 | |
| 3,412,000,000 | |
| 3,278,000,000 | |
| 1,205,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 899,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,197,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 989,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 855,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 3,996,516,745 | |
| 0 |